MyoKardia Competitors and Similar CompaniesClear all

MyoKardia's competitors and similar companies include FORMA Therapeutics, AbbVie, Abbott and Vertex Pharmaceuticals.

	MyoKardia MyoKardia is a company that discovers, develops, and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.	FORMA Therapeutics FORMA Therapeutics is a biopharmaceutical company intended for the discovery, development, and commercialization of transformative medicines.	AbbVie AbbVie is a pharmaceutical company engaged in the research, development, manufacturing, commercialization, and sale of medicines and therapies.	Abbott Abbott Laboratories is a company that specializes in the discovery, development, manufacture, and sale of healthcare products.	Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines.
Founding Date	Founding Date 2012	Founding Date 2008	Founding Date 2013	Founding Date 1888	Founding Date 1989
Type	Type Subsidiary	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare drug development medical devices medical diagnostics nutrition pharma women's health	Tags Healthcare biotech drug development pharma
Locations	Locations South San Francisco, US HQ Brisbane, US	Locations Watertown, US HQ	Locations North Chicago, US HQ Hydra, DZ Buenos Aires, AR Mascot, AU Wien, AT Wavre, BE Sarajevo, BA see more	Locations Abbott Park, US HQ Tiranë, AL Buenos Aires, AR Yerevan, AM Doncaster, AU East Brisbane, AU Macquarie Park, AU see more	Locations Boston, US HQ St Leonards, AU Wien, AT Bruxelles, BE São Paulo, BR Toronto, CA Praha, CZ see more
Employees	Employees 23542% increase	Employees 77	Employees 55,00010% increase	Employees 114,000	Employees 5,40013% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 998.7 m	Valuation ($) 335 b	Valuation ($) 196.1 b	Valuation ($) 121.4 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $61.2b (FY, 2025)	Revenue (est.) $44.3b (FY, 2025)	Revenue (est.) $12b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $18.2b (FY, 2025)	Cost of goods $19.3b (FY, 2025)	Cost of goods $1.7b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $43b (FY, 2025)	Gross profit $25b (FY, 2025)	Gross profit $10.4b (FY, 2025)
Net income	Net income ($276.2m) (FY, 2019)	Net income ($173m) (FY, 2021)	Net income $4.2b (FY, 2025)	Net income $6.5b (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised $ 98m	Total funding raised $ 142.5m	Total funding raised $ 3.8b	Total funding raised N/A	Total funding raised $ 2.4m